- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Patients of Myeloproliferative neoplasms are at high risk of infection: Study
Hematologic malignancies accounted for 9% of all newly diagnosed cancers in the United States. Infections are a common complication in patients with many hematologic malignancies.
A new study by Anna Ravn Landtblom and team reported that Myeloproliferative Neoplasms (MPN) patients were at higher risk of infection. This study is published in leukemia journal.
The objective of the study was to assess whether patients with myeloproliferative neoplasms (MPN) also are at an increased risk of infections.
A large population-based matched cohort study was conducted in Sweden including 8,363 MPN patients and 32,405 controls using high-quality registers between the years 1992–2013 with follow-up until 2015.
The results of the study were found to be
• The hazard ratio (HR) of any infection was found to be 2.0 (95% confidence interval 1.9–2.0), of bacterial infections 1.9 (1.8–2.0).
• Viral infections was found to be 2.1 (1.9–2.3). One of the largest risk increases was that of sepsis, HR 2.6 (2.4–2.9).
• The HR of any infection was highest in primary myelofibrosis 3.7 (3.2–4.1), and significantly elevated in all MPN subtypes; 1.7 (1.6–1.8) in polycythemia vera and 1.7 (1.5–1.8) in essential thrombocythemia.
• There was no significant difference in risk of infections between untreated patients and patients treated with hydroxyurea or interferon-α during the years 2006–2013.
Landtblom and team concluded that "These novel findings of an overall increased risk of infections in MPN patients, irrespective of common cytoreductive treatments, suggest the increased risk of infection is inherent to the MPN."
For further information: https://doi.org/10.1038/s41375-020-0909-7
Medical Dialogues consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751